1,075
Views
26
CrossRef citations to date
0
Altmetric
Laboratory Study

Protective Effect of Infliximab on Ischemia/Reperfusion-Induced Damage in Rat Kidney

, , , , , , & show all
Pages 1144-1149 | Received 18 Apr 2012, Accepted 18 Jul 2010, Published online: 06 Sep 2012

Figures & data

Table 1. Effects of infliximab on MDA, MPO, GSH and SOD levels in rats exposed to renal I/R.

Table 2. The comparison of severity of renal damage among groups.

Figure 1. (A) Sham; renal tubules and glomeruli are intact. H&E ×66. (B) Sham; appearance of brush border (arrows). PAS ×132. (C) I/R group; tubules show diffuse and marked necrosis (*). H&E ×66. (D) I/R group; notice lost of the brush border and glomerular changes. PAS ×132. (E) I/R + infliximab (bi); despite tubular degeneration are visible in some area, glomeruli are seen intact. H&E ×66. (F) I/R + infliximab (bi); the loss of brush border was marked in affected tubules. PAS ×132. (G) I/R+ infliximab (br); moderate tubular damage and interstitial congestion are observed. H&E ×66. (H) I/R+ infliximab (br); the view of brush border is similar to ischemia group. PAS ×132.

Figure 1. (A) Sham; renal tubules and glomeruli are intact. H&E ×66. (B) Sham; appearance of brush border (arrows). PAS ×132. (C) I/R group; tubules show diffuse and marked necrosis (*). H&E ×66. (D) I/R group; notice lost of the brush border and glomerular changes. PAS ×132. (E) I/R + infliximab (bi); despite tubular degeneration are visible in some area, glomeruli are seen intact. H&E ×66. (F) I/R + infliximab (bi); the loss of brush border was marked in affected tubules. PAS ×132. (G) I/R+ infliximab (br); moderate tubular damage and interstitial congestion are observed. H&E ×66. (H) I/R+ infliximab (br); the view of brush border is similar to ischemia group. PAS ×132.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.